Clinical Oncology

Papers
(The H4-Index of Clinical Oncology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status78
Assessing the Tolerability of Adjuvant and Neoadjuvant Chemotherapy in the Treatment of Early and Locally Advanced Breast Cancer in the Elderly Population at a UK Tertiary Cancer Centre75
RCR Meetings45
RCR Meetings43
Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults – Is There a Difference in Outcome?41
Vascular Interventions in Oncology40
Dosimetry in the Prediction and Reduction of Acute Skin Toxicity from the Use of Brass Bolus in Postmastectomy Chest Wall Radiotherapy Treatment39
OncoFlash–Research Updates in a Flash! (December 2022)39
Hypofractionated Radiation Therapy in Keratinocyte Carcinoma38
Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis38
Instant Oncology: Impower13333
OncoFlash – Research Updates in a Flash! (June 2022)32
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital30
Contact X-ray brachytherapy (CXB) for early rectal cancer: A review of outcomes from a single UK centre30
An educational initiative to develop radiotherapy-specific teaching following the introduction of the oncology common stem year30
The First Use of Stereotactic Ablative Body Radiotherapy (SABR) in Extra-cranial Non-lung Oligometastatic Disease: A Single Centre29
Improving Palliative Radiotherapy Training: A Multi-professional, Combined Clinical and Training Improvement Project28
Ayrshire Men Diagnosed with Locally Advanced Prostate Cancer between 2012 and 2013; How do they do?28
The Time has Come to Say Goodbye27
Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian Cancer in the UK: Results From the KNOW-OC Survey25
What can the Interventional Endoscopist Offer in the Management of Upper Gastrointestinal Malignancies?25
Response Letter to Laurelli et al. Letter to the Editor Regarding Enhancing Telemedicine to Improve Global Radiotherapy Access24
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Re23
0.11704111099243